Fibromyalgia Syndrome: Novel Therapeutic Targets

References

• Crofford LJ , ClauwDJ . Fibromyalgia: where are we a decade after the American College of Rheumatology classification criteria were developed?Arthritis Rheum.46 ( 5 ), 1136 – 1138 ( 2002 ).
   PubMedGoogle Scholar
• Hadler NM . “Fibromyalgia” and the medicalization of misery . J. Rheumatol.30 ( 8 ), 1668 – 1670 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Chang P-F , Arendt-NielsenL , Graven-NielsenT , ChenAC . Psychophysical and EEG responses to repeated experimental muscle pain in humans: pain intensity encodes EEG activity . Brain Res. Bull.59 ( 6 ), 533 – 543 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Bragdon EE , LightKC , CostelloNLet al. Group differences in pain modulation: pain-free women compared with pain-free men and to women with TMD . Pain96 ( 3 ), 227 – 237 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Bendtsen L . Central sensitization in tension-type headache – possible pathophysiological mechanisms . Cephalalgia20 ( 5 ), 486 – 508 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Ablin JN , BuskilaD . Personalized treatment of pain . Curr. Rheumatol. Rep.15 ( 1 ), 1 – 6 ( 2013 ).
   Web of Science ®Google Scholar
• Jensen MP , DayMA , MiróJ . Neuromodulatory treatments for chronic pain: efficacy and mechanisms . Nat. Rev. Neurol.10 ( 3 ), 167 – 178 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wolfe F , SmytheHA , YunusMBet al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia . Arthritis Rheum.33 ( 2 ), 160 – 172 ( 1990 ).
   PubMed Web of Science ®Google Scholar
• Wolfe F , ClauwDJ , FitzcharlesM-Aet al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia . J. Rheumatol.38 ( 6 ), 1113 – 1122 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Woolf CJ . Evidence for a central component of post-injury pain hypersensitivity . Nature306 ( 5944 ), 686 – 688 ( 1983 ).
   PubMed Web of Science ®Google Scholar
• Yunus MB . Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness . Semin. Arthritis Rheum.37 ( 6 ), 339 – 352 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Yarnitsky D . Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states . Curr. Opin. Anesthesiol.23 ( 5 ), 611 – 615 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Abeles AM , PillingerMH , SolitarBM , AbelesM . Narrative review: the pathophysiology of fibromyalgia . Ann. Intern. Med.146 ( 10 ), 726 – 734 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Moldofsky H . The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fibromyalgia syndrome . Rheum. Dis. Clin. North Am.35 ( 2 ), 275 – 283 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Napadow V , LaCountL , ParkK , As-SanieS , ClauwDJ , HarrisRE . Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity . Arthritis Rheum.62 ( 8 ), 2545 – 2555 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Napadow V , KimJ , ClauwDJ , HarrisRE . Brief report: decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia . Arthritis Rheum.64 ( 7 ), 2398 – 2403 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Fink K , DooleyDJ , MederWPet al. Inhibition of neuronal Ca 2+ influx by gabapentin and pregabalin in the human neocortex . Neuropharmacology42 ( 2 ), 229 – 236 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Bian F , HannahD , CampbellB . Calcium channel alpha2-delta type 2 subunit is the major binding protein for pregabalin in cerebellum and septum: an ex vivo autoradiographic study in wild-type and genetically modified mice . Neuroscience2008 , 15 – 19 ( 2008 ).
   Google Scholar
• Crofford LJ , RowbothamMC , MeasePJet al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial . Arthritis Rheum.52 ( 4 ), 1264 – 1273 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Hindmarch I , DawsonJ , StanleyN . A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo . Sleep28 ( 2 ), 187 – 193 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Arnold LM , GoldenbergDL , StanfordSBet al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial . Arthritis Rheum.56 ( 4 ), 1336 – 1344 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Häuser W , BernardyK , ÜçeylerN , SommerC . Treatment of fibromyalgia syndrome with gabapentin and pregabalin-a meta-analysis of randomized controlled trials . Pain145 ( 1 ), 69 – 81 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• North JM , HongKsJ , RauckRL . The effect of a novel form of extended-release gabapentin on pain and sleep in fibromyalgia subjects: an open-label pilot study . Pain Pract. doi:10.1111/papr.12319 ( 2015 ) ( Epub ahead of print ).
   PubMed Web of Science ®Google Scholar
• Bialer M . Chemical properties of antiepileptic drugs (AEDs) . Adv. Drug Deliv. Rev.64 ( 10 ), 887 – 895 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wymer JP , SimpsonJ , SenD , BongardtS , GroupLSS . Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens . Clin. J. Pain25 ( 5 ), 376 – 385 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Errington AC , StöhrT , HeersC , LeesG . The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels . Mol. Pharmacol.73 ( 1 ), 157 – 169 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Shaibani A , FaresS , SelamJ-Let al. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial . J. Pain10 ( 8 ), 818 – 828 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Beyreuther BK , GeisC , StöhrT , SommerC . Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF . Neuropharmacology52 ( 5 ), 1312 – 1317 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Hearn L , DerryS , MooreRA . Lacosamide for neuropathic pain and fibromyalgia in adults . Cochrane Database Syst. Rev.2 , CD009318 ( 2012 ).
   Google Scholar
• Sultan A , GaskellH , DerryS , MooreAR . Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials . BMC Neurol.8 ( 1 ), 29 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Clauw DJ , MeaseP , PalmerRH , GendreauRM , WangY . Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial . Clin. Ther.30 ( 11 ), 1988 – 2004 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Häuser W , PetzkeF , ÜçeylerN , SommerC . Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis . Rheumatology50 ( 3 ), 532 – 543 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Krell HV , LeuchterAF , CookIA , AbramsM . Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain . Psychosomatics46 ( 5 ), 379 – 384 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Arnold LM , HirschI , SandersP , EllisA , HughesB . Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial . Arthritis Rheum.64 ( 7 ), 2387 – 2397 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Smith JA , PatilD , DanielsOet al. Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor . Int. J. Neuropsychopharmacol.18 ( 2 ), pii: pyu027 ( 2014 ).
   Web of Science ®Google Scholar
• Piercarlo S-P , ChiaraGM , AlbertoB , RossellaT , ManuelaDF , FabiolaA . Novel pharmaceutical options for treating fibromyalgia . Expert Rev. Clin. Pharmacol. doi:10.1586/17512433.2016.1145052 ( 2016 ) ( Epub ahead of print ).
   Web of Science ®Google Scholar
• Wood PB , SchweinhardtP , JaegerEet al. Fibromyalgia patients show an abnormal dopamine response to pain . Eur. J. Neurosci.25 ( 12 ), 3576 – 3582 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Holman AJ , MyersRR . A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications . Arthritis Rheum.52 ( 8 ), 2495 – 2505 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Holman AJ . Ropinirole, open preliminary observations of a dopamine agonist for refractory fibromyalgia . J. Clin. Rheumatol.9 ( 4 ), 277 – 279 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Distler O , EichW , DokoupilovaEet al. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study . Arthritis Rheum.62 ( 1 ), 291 – 300 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Carville SF , Arendt-NielsenS , BliddalHet al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome . Ann. Rheum. Dis.67 ( 4 ), 536 – 541 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Sommer C , HäuserW , AltenRet al. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline] . Schmerz (Berlin, Germany)26 ( 3 ), 297 – 310 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Mathias CJ . L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension . Clin. Auton. Res.18 ( 1 ), 25 – 29 ( 2008 ).
   PubMedGoogle Scholar
• Khasabov SG , RogersSD , GhilardiJR , PetersCM , MantyhPW , SimoneDA . Spinal neurons that possess the substance P receptor are required for the development of central sensitization . J. Neurosci.22 ( 20 ), 9086 – 9098 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Russell IJ , OrrMD , LittmanBet al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome . Arthritis Rheum.37 ( 11 ), 1593 – 1601 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Herrstedt J , ApornwiratW , ShaharyarAet al. Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy . J. Clin. Oncol.27 ( 32 ), 5363 – 5369 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Younger J , NoorN , McCueR , MackeyS . Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels . Arthritis Rheum.65 ( 2 ), 529 – 538 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Mattioli T-AM , MilneB , CahillCM . Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats . Mol. Pain6 ( 1 ), 1 ( 2010 ).
   PubMedGoogle Scholar
• Ponomarev ED , VeremeykoT , WeinerHL . MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS . Glia61 ( 1 ), 91 – 103 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Cravatt BF , LichtmanAH . The endogenous cannabinoid system and its role in nociceptive behavior . J. Neurobiol.61 ( 1 ), 149 – 160 ( 2004 ).
   PubMedGoogle Scholar
• Smith SC , WagnerMS . Clinical endocannabinoid deficiency (CECD) revisited: can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?Neuro. Endocrinol. Lett.35 ( 3 ), 198 – 201 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Skrabek RQ , GalimovaL , EthansK , PerryD . Nabilone for the treatment of pain in fibromyalgia . J. Pain9 ( 2 ), 164 – 173 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Ware MA , FitzcharlesM-A , JosephL , ShirY . The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial . Anesth. Analg.110 ( 2 ), 604 – 610 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Staud R , KooEB . Are cannabinoids a new treatment option for pain in patients with fibromyalgia?Nat. Clin. Pract. Rheumatol.4 ( 7 ), 348 – 349 ( 2008 ).
   PubMedGoogle Scholar
• Bagge E , BengtssonB , CarlssonL , CarlssonJ . Low growth hormone secretion in patients with fibromyalgia – a preliminary report on 10 patients and 10 controls . J. Rheumatol.25 ( 1 ), 145 – 148 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Bennett RM , ClarkSC , WalczykJ . A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia . Am. J. Med.104 ( 3 ), 227 – 231 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Cuatrecasas G , GonzalezM , AlegreCet al. High prevalence of growth hormone deficiency in severe fibromyalgia syndromes . J. Clin. Endocrinol. Metab.95 ( 9 ), 4331 – 4337 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Cuatrecasas G , AlegreC , Fernandez-SolàJet al. Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia . Pain153 ( 7 ), 1382 – 1389 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Jones K , BurckhardtC , DeodharAA , PerrinN , HansonG , BennettR . A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia . Arthritis Rheum.58 ( 2 ), 612 – 622 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Jones KD , BurckhardtCS , DeodharAA , PerrinNA , HansonGC , BennettRM . A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia . Arthritis Rheum.58 ( 2 ), 612 – 622 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Dougherty P , PalecekJ , PaleckovaV , SorkinL , WillisW . The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli . J. Neurosci.12 ( 8 ), 3025 – 3041 ( 1992 ).
   PubMed Web of Science ®Google Scholar
• Woolf CJ , SalterMW . Neuronal plasticity: increasing the gain in pain . Science288 ( 5472 ), 1765 – 1769 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Staud R , VierckCJ , RobinsonME , PriceDD . Effects of the N-methyl-D-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects . J. Pain6 ( 5 ), 323 – 332 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Cohen SP , VerdolinMH , ChangAS , KuriharaC , MorlandoBJ , MaoJ . The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients . J. Pain7 ( 6 ), 398 – 391 ( 2006 ).
   Web of Science ®Google Scholar
• Johnson JW , KotermanskiSE . Mechanism of action of memantine . Curr. Opin. Pharmacol.6 ( 1 ), 61 – 67 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Harris RE , SundgrenPC , CraigAet al. Elevated insular glutamate in fibromyalgia is associated with experimental pain . Arthritis Rheum.60 ( 10 ), 3146 – 3152 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Harris RE , SundgrenPC , PangYet al. Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia . Arthritis Rheum.58 ( 3 ), 903 – 907 ( 2008 ).
   PubMedGoogle Scholar
• Sang CN , BooherS , GilronI , ParadaS , MaxMB . Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia efficacy and dose-response trials . Anesthesiology96 ( 5 ), 1053 – 1061 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Olivan-Blázquez B , Herrera-MercadalP , Puebla-GuedeaMet al. Efficacy of memantine in the treatment of fibromyalgia: a double-blind, randomised, controlled trial with 6-month follow-up . Pain155 ( 12 ), 2517 – 2525 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Khalid S , SoomroBA , MahmoodZ . Efficacy of memantine in treating patients with fibromyalgia . Pakistan J. Neurol. Sci.10 ( 3 ), 31 – 36 ( 2015 ).
   Google Scholar
• Recla JM , SarantopoulosCD . Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and neuroprotective strategy?Med. Hypotheses73 ( 2 ), 177 – 183 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Srinivasan V , Pandi-PerumalSR , SpenceDWet al. Potential use of melatonergic drugs in analgesia: mechanisms of action . Brain Res. Bull.81 ( 4 ), 362 – 371 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Pandi-Perumal SR , SrinivasanV , SpenceDWet al. Ramelteon: a review of its therapeutic potential in sleep disorders . Adv. Ther.26 ( 6 ), 613 – 626 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Demyttenaere K . Agomelatine: a narrative review . Eur. Neuropsychopharmacol.21 ( Suppl. 4 ), S703 – S709 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bruno A , MicòU , LorussoSet al. Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study . J. Clin. Psychopharmacol.33 ( 4 ), 507 – 511 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Calandre E , SlimM , Garcia-LeivaJ , Rodriguez-LopezC , TorresP , Rico-VillademorosF . Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: an uncontrolled, 12-week, pilot study . Pharmacopsychiatry47 ( 2 ), 67 – 72 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Vergne-Sallel P , Dufauret-LombardlC , BonnetlCet al. A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia . Eur. J. Pain15 ( 5 ), 509 – 514 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Tolk J , KohnenR , MüllerW . Intravenous treatment of fibromyalgia with the 5-HT3 receptor antagonist tropisetron in a rheumatological practice . Scand. J. Rheumatol.33 ( Suppl. 119 ), 72 – 75 ( 2004 ).
   Google Scholar
• Seidel MF , WeinreichGF , StratzT , MüllerW . 5-HT3 receptor antagonists regulate autonomic cardiac dysfunction in primary fibromyalgia syndrome . Rheumatology Int.27 ( 11 ), 1025 – 1030 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Schwartz TL , RayanchaS , RashidA , ChlebowksiS , ChiltonM , MorellM . Modafinil treatment for fatigue associated with fibromyalgia . J. Clin. Rheumatol.13 ( 1 ), 52 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Schaller JL , BeharD . Modafinil in fibromyalgia treatment . J. Neuropsychiatry Clin. Neurosci.13 ( 4 ), 530 – 531 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Schwartz TL , SiddiquiUA , RazaS , MorellM . Armodafinil for fibromyalgia fatigue . Ann. Pharmacother.44 ( 7–8 ), 1347 – 1348 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Pardi D , BlackJ . γ-hydroxybutyrate/sodium oxybate . CNS Drugs20 ( 12 ), 993 – 1018 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Pardi D , BlackJ . gamma-hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness . CNS Drugs20 ( 12 ), 993 – 1018 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Spaeth M , BennettRM , BensonBA , WangYG , LaiC , ChoyEH . Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international Phase 3 trial . Ann. Rheum. Dis.71 ( 6 ), 935 – 942 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Russell IJ , HolmanAJ , SwickTJet al. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study . Pain152 ( 5 ), 1007 – 1017 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Moldofsky H , InhaberNH , GuintaDR , Alvarez-HorineSB . Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study . J. Rheumatol.37 ( 10 ), 2156 – 2166 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Staud R . Sodium oxybate for the treatment of fibromyalgia . Expert Opin. Pharmacother.12 ( 11 ), 1789 – 1798 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ortancil O , SanliA , EryukselR , BasaranA , AnkaraliH . Association between serum ferritin level and fibromyalgia syndrome . Eur. J. Clin. Nutr.64 ( 3 ), 308 – 312 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Mader R , KotonY , BuskilaD , HererP , EliasM . Serum iron and iron stores in non-anemic patients with fibromyalgia . Clin. Rheumatol.31 ( 4 ), 595 – 599 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kawamura M , OharaH , GoK , KogaY , IenagaK . Neurotropin induces antinociceptive effect by enhancing descending pain inhibitory systems involving 5-HT 3 and noradrenergic α 2 receptors in spinal dorsal horn . Life Sci.62 ( 24 ), 2181 – 2190 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Okazaki R , NambaH , YoshidaH , OkaiH , MiuraT , KawamuraM . The antiallodynic effect of neurotropin® is mediated via activation of descending pain inhibitory systems in rats with spinal nerve ligation . Anesth. Analg.107 ( 3 ), 1064 – 1069 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Okai H , OkazakiR , KawamuraM , YoshimuraM . Excitatory effect of Neurotropin® on noradrenergic neurons in rat locus coeruleus . Life Sci.136 , 79 – 86 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bassler D , MitraA , DucharmeFM , ForsterJ , SchwarzerG . Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children . Cochrane Database Syst Rev.1 , CD001384 ( 2004 ).
   Google Scholar
• Sokol KC , AmarNK , StarkeyJ , GrantJA . Ketotifen in the management of chronic urticaria: resurrection of an old drug . Ann. Allergy Asthma Immunol.111 ( 6 ), 433 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Blanco I , BéritzeN , ArgüellesMet al. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients . Clin. Rheumatol.29 ( 12 ), 1403 – 1412 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Klooker TK , BraakB , KoopmanKEet al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome . Gut59 ( 9 ), 1213 – 1221 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ang DC , HilligossJ , StumpT . Mast cell stabilizer (ketotifen) in fibromyalgia: Phase 1 randomized controlled clinical trial . Clin. J. Pain31 ( 9 ), 836 – 842 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• McIntyre A , PaisleyD , KouassiE , GendronA . quetiapine fumarate extended-release for the treatment of major depression with comorbid fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study . Arthritis Rheum.66 ( 2 ), 451 – 461 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lister R . An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome . J. Int. Med. Res.30 ( 2 ), 195 – 199 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Miyamae T , SekiM , NagaTet al. Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation . Redox Rep.18 ( 1 ), 12 – 19 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Cordero MD , Alcocer-GómezE , de MiguelMet al. Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia? Antioxid. Redox Signal. 19 ( 12 ), 1356 – 1361 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Jensen KB , LoitoileR , KosekEet al. Patients with fibromyalgia display less functional connectivity in the brain’s pain inhibitory network . Mol. Pain8 , 32 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Harris RE , NapadowV , HugginsJPet al. Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients . Anesthesiology119 ( 6 ), 1453 – 1464 ( 2013 ).
   PubMed Web of Science ®Google Scholar